Search - tctmd.com

Displaying 21 - 40 of 853

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2025

Michael O'Riordan

December 29, 2025

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Daily News

Year in Review: Evidence Around AI in Cardiology Grows

Todd Neale

December 23, 2025

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

WHO Endorses Treating Obesity in Adults With GLP-1s

Todd Neale

December 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

Caitlin E. Cox

December 01, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Daily News

Chronic Pain Linked to Increased Risk for Incident Hypertension

L.A. McKeown

November 20, 2025

News Daily News

Online Calculator Allows Young Adults to See How Their 30-Year CV Risk Compares to Peers’

Yael L. Maxwell

November 19, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Yael L. Maxwell

October 24, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Bax24: Baxdrostat Successful Again, This Time in Resistant Hypertension

Todd Neale

October 07, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2025

Year in Review: Top Prevention Stories of 2025

December 2025 Dispatch for the CV Team

Year in Review: Evidence Around AI in Cardiology Grows

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

WHO Endorses Treating Obesity in Adults With GLP-1s

TCTMD’s Top 10 Most Popular Stories for November 2025

November 2025 Dispatch for the CV Team

Chronic Pain Linked to Increased Risk for Incident Hypertension

Online Calculator Allows Young Adults to See How Their 30-Year CV Risk Compares to Peers’

What’s Going to Be Hot at AHA 2025?

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

What’s Going to Be Hot at TCT 2025

Bax24: Baxdrostat Successful Again, This Time in Resistant Hypertension

ACC: It’s Time for Clinicians to Address Inflammation in CVD

TCTMD’s Top 10 Most Popular Stories for September 2025

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content